Check out our most popular compounded medications! Get Started
The Terbutaline Sulfate 2.5 mg Troche is a square-shaped solid dosage form that dissolves slowly in the mouth. It delivers medication through oral mucosa absorption for targeted local or systemic effects. This formulation is used to treat conditions such as asthma, chronic obstructive pulmonary disease, bronchospasm, bronchitis, and emphysema.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Terbutaline Sulfate 2.5 mg Troche is a specially compounded medication primarily used for the treatment of various respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and exercise-induced bronchospasm. It also finds use in the management of preterm labor. Terbutaline Sulfate is a bronchodilator that functions by relaxing the muscles in the airways, thereby facilitating easier breathing.
This particular formulation is a troche, a square-shaped solid dosage form that is designed to dissolve slowly in the mouth. Unlike traditional oral medications, troches deliver medication through absorption via the oral mucosa. This method of delivery can provide targeted local or systemic effects, depending on the medication and the condition being treated.
The slow dissolution of the troche in the mouth allows for a sustained release of the medication over a period of time. This slow-release mechanism ensures a more consistent therapeutic effect, providing relief over a longer duration compared to conventional dosage forms.
The recommended dosage of Terbutaline Sulfate 2.5 mg Troche is one troche every 12 hours. It is crucial to adhere to the dosage instructions provided by your healthcare provider to ensure optimal therapeutic outcomes. If you have any queries regarding this formulation or its usage, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive information to help you understand your medication better.
Terbutaline Sulfate 2.5 mg Troche is a compounded formulation designed as a bronchodilator to manage respiratory conditions such as asthma and bronchitis. This square-shaped solid dosage form is intended to dissolve slowly in the mouth, allowing the medication to be absorbed through the oral mucosa for targeted local or systemic effects. It functions by relaxing the muscles in the airways, thereby facilitating increased airflow in and out of the lungs.
It is crucial to understand that terbutaline sulfate is not intended to treat an ongoing asthma attack. Potential side effects of this medication may include dizziness, headache, nausea, and nervousness. Patients are advised to refrain from driving or operating machinery until the effects of the medication have subsided. Furthermore, terbutaline sulfate may interact with other medications such as beta-blockers, diuretics, and MAO inhibitors. Therefore, patients should disclose all medications they are currently taking to their healthcare provider before initiating treatment with terbutaline sulfate.
Healthcare providers prescribing terbutaline sulfate should be aware that it may cause an increase in heart rate and blood pressure. Regular monitoring of these parameters is recommended for patients under this medication. Additionally, potential interactions with other medications such as beta-blockers, diuretics, and MAO inhibitors should be considered.
If you have any queries regarding the use of terbutaline sulfate 2.5 mg Troche, please do not hesitate to reach out for further information.
Terbutaline Sulfate 2.5 mg Troche is a therapeutic formulation primarily used in the management of asthma, bronchospasm, and other conditions associated with airway obstruction. The medication functions by relaxing the muscles in the airways, thereby facilitating improved airflow and alleviating symptoms associated with asthma and other related conditions.
The troche form of Terbutaline Sulfate is a square-shaped solid dosage form, designed to dissolve slowly in the mouth. Unlike traditional tablets, this troche is not swallowed but placed under the tongue where it gradually dissolves. This unique delivery method allows the medication to be absorbed directly through the oral mucosa into the bloodstream, offering a more immediate relief compared to other dosage forms of Terbutaline Sulfate.
The recommended dosage for Terbutaline Sulfate 2.5 mg Troche is one troche every four to six hours, or as directed by a healthcare professional. It is crucial to adhere to your doctor's instructions when taking this medication to ensure its efficacy and to minimize potential side effects. If you have any queries or concerns about the usage of Terbutaline Sulfate 2.5 mg Troche, it is advisable to consult with your healthcare provider or pharmacist.
Terbutaline Sulfate 2.5 mg Troche is a square-shaped solid dosage form that is designed to dissolve slowly in the mouth. This unique formulation allows for the medication to be absorbed through the oral mucosa, providing targeted local or systemic effects. This medication may be used to treat a variety of conditions including exercise-induced bronchospasm, preterm labor, and to prevent bronchospasm in patients undergoing bronchoscopy. It may also be beneficial in treating pulmonary conditions such as edema, hypertension, and fibrosis. Furthermore, it can be used to alleviate symptoms of allergic rhinitis, including sneezing, nasal congestion, and itchy eyes. However, it is crucial to understand that terbutaline sulfate should not be used to treat acute asthma attacks. If you have any questions or concerns about the use of terbutaline sulfate 2.5 mg troche for any of these conditions, please do not hesitate to reach out for further information.
Terbutaline Sulfate 2.5 mg Troche is a square-shaped solid dosage form of the medication Terbutaline Sulfate. It is designed to dissolve slowly in the mouth, delivering the medication through absorption by the oral mucosa for targeted local or systemic effects.
Terbutaline Sulfate 2.5 mg Troche works by slowly dissolving in the mouth and being absorbed through the oral mucosa. This allows for the medication to be delivered directly to the targeted area, either locally or systemically, depending on the intended effect.
Terbutaline Sulfate 2.5 mg Troche should be placed in the mouth and allowed to dissolve slowly. It should not be chewed or swallowed whole. The exact dosage and frequency will be determined by your healthcare provider.
As with any medication, Terbutaline Sulfate 2.5 mg Troche can have side effects. These can include dry mouth, nausea, headache, and dizziness. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
It's important to discuss all medications you're currently taking with your healthcare provider before starting Terbutaline Sulfate 2.5 mg Troche. Some medications may interact with Terbutaline Sulfate, altering its effectiveness or causing adverse effects.
Individuals with certain medical conditions, such as severe heart disease, high blood pressure, or diabetes, may not be suitable candidates for Terbutaline Sulfate 2.5 mg Troche. Always discuss your medical history with your healthcare provider before starting any new medication.
If you miss a dose of Terbutaline Sulfate 2.5 mg Troche, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
Terbutaline Sulfate 2.5 mg Troche should be stored at room temperature, away from light and moisture. Keep it out of reach of children and pets.
It's best to discuss this with your healthcare provider, as alcohol can interact with many medications. In general, it's usually recommended to avoid or limit alcohol consumption while taking medication.
If you suspect an overdose of Terbutaline Sulfate 2.5 mg Troche, seek emergency medical attention immediately. Symptoms of an overdose can include chest pain, fast or irregular heartbeat, severe headache, and fainting.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
